William A. Schleif - Concepedia

Author

William A. Schleif

Also Known As

Schleif, W., Schleif, W.A., W A Schleif, W. A. SCHLEIF, W. A. Schleif, W. SCHLEIF, W. Schleif, WILLIAM A. SCHLEIF, WILLIAM SCHLEIF, William A Schleif

136

Publications

15.1K

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)

About

William A. Schleif is an author at United States Military Academy specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	85	11.4K
2	Biochemistry	20	28	2.4K
3	Natural Sciences	16	19	3.1K
4	Allergy	3	3	213
5	Engineering	1	1	11

William A. Schleif

103

Publications

15K

Citations

H-Index

Page 1

	Year	Citations
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy Roy M. Gulick, John W. Mellors, Diane V. Havlir, New England Journal of Medicine	1997	1.9K
Active human immunodeficiency virus protease is required for viral infectivity. Nancy E. Kohl, Emilio A. Emini, William A. Schleif, Proceedings of the National Academy of Sciences Protease InhibitorsViral ReplicationMolecular VirologyHiv ProteaseHuman Retrovirus	1988	1.3K
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity John W. Shiver, Tong‐Ming Fu, Ling Chen, Nature VaccinationHuman RetrovirusImmunologyAntiviral ResponseVirology	2002	1.2K
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells Daria J. Hazuda, Peter J. Felock, Marc Witmer, Science Hiv-1 IntegraseViral ReplicationImmunologyMolecular BiologyStrand Transfer	2000	1.1K
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors Jon H. Condra, William A. Schleif, O M Blahy, Nature Protease InhibitorsHuman RetrovirusImmunologyAntiviral ResponseAntiviral Drug Development	1995	978
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. Joseph P. Vacca, Bruce D. Dorsey, William A. Schleif, Proceedings of the National Academy of Sciences ImmunologyCell CulturePharmacotherapyAntiviral DrugMedicinal Chemistry	1994	526
Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody Emilio A. Emini, William A. Schleif, Jack H. Nunberg, Nature Human RetrovirusImmunologyAntiviral TherapyAntiviral ResponseVirology	1992	475
L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor Bruce D. Dorsey, Rhonda B. Levin, Stacey L. McDaniel, Journal of Medicinal Chemistry	1994	408
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor Jon H. Condra, Daniel Holder, William A. Schleif, Journal of Virology ImmunologyVivo Viral ResistanceMolecular BiologyAntiviral DrugPrimary Hiv-1 Isolates	1996	405
Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors Jack H. Nunberg, William A. Schleif, Evelyn Boots, Journal of Virology ImmunologyMolecular BiologyCell CultureAntiviral DrugDrug Resistance	1991	363

Page 1